Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic AlterationsMichele Simbolo, Emilio Bria|Journal of Thoracic Oncology|2019Cited by 104
Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future PerspectivesMiriam Grazia Ferrara, Emilio Bria|Cancers|2020Cited by 94
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future OpportunitiesMiriam Grazia Ferrara, Emilio Bria|Frontiers in Oncology|2021Cited by 54
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?Giovanna Garufi, Fabio Puglisi, Luisa Carbognin et al.|Cancer Treatment Reviews|2022Cited by 20
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studiesFederica Miglietta, Valentina Guarneri, Laura Merlini et al.|European Journal of Cancer|2023Cited by 14